Kim, Y. J., Chan, S. L., Tai, D., Kim, H., Chan, L., Liu, T., Kim, I. H., Lee, J. J. X., Hsu, C., Yoo, C. (2026). Survival outcomes in patients (pts) with Child-Pugh class B (CP-B) liver function at progression after first-line atezolizumab-bevacizumab (Atezo-Bev) for unresectable hepatocellular carcinoma (uHCC): Asia-Pacific multicenter retrospective analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.553